Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned

Advances in oncology research have led to identification of tumor-specific biomarkers, some of which are important predictive indicators and ideal targets for novel therapeutics. One such biomarker in non-small cell lung cancer (NSCLC) is the epidermal growth factor receptor (EGFR). Patients with NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dae Ho, Srimuninnimit, Vichien, Cheng, Rebecca, Wang, Xin, Orlando, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614211/
https://www.ncbi.nlm.nih.gov/pubmed/25943319
http://dx.doi.org/10.4143/crt.2014.362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614211/
https://www.ncbi.nlm.nih.gov/pubmed/25943319
http://dx.doi.org/10.4143/crt.2014.362

Ejemplares similares